Literature DB >> 9652513

Power Doppler sonography: clinical applications.

C Martinoli1, F Pretolesi, G Crespi, S Bianchi, N Gandolfo, M Valle, L E Derchi.   

Abstract

OBJECTIVE: Color Doppler imaging (CD) has had a great impact on ultrasonography (US). This technique depicts local flow by encoding an estimate of the mean Doppler frequency shift at a particular position in color. However, the choice of the mean frequency shift as the parameter for representing flow in color Doppler is somewhat arbitrary. Power Doppler ultrasound is a technique that encodes the power in the Doppler signal in color. This parameter is fundamentally different from the mean frequency shift. The frequency is determined by the velocity of the red blood cells, while the power depends on the amount of blood present. Providing an image of a different property of blood flow, power Doppler has shown several key advantages over colour Doppler, including higher sensitivity to flow, better edge definition and depiction of continuity of flow. In this paper we review the results of power Doppler clinical studies.
MATERIALS AND METHODS: All relevant information available in the literature on the potential clinical applications of this technique was revised to give a detailed survey.
RESULTS: The increased flow sensitivity and better vascular detailing of power Doppler have been used to detect flow presence and characteristics in vessels that are poorly imaged with conventional color Doppler. The improved depiction of tissue vasculature has shown potential advantages, especially in some areas, such as the cortex of native kidneys and renal allografts, the prepuberal testis, the infant hip and the bowel wall, in which color Doppler is not sensitive enough to detect clinically important, slow and poor flow in small vessels. In inflammatory conditions, power Doppler was valuable in depicting increased flow in vessels that are dilated because of inflammatory response. In this field, advantages have been reported in acute cholecystitis and in inflammatory states of musculoskeletal tissues. The higher sensitivity to slow flow and the improved detailing of the course of tortuous and irregular vessels made power Doppler a promising technique to image intratumoral vessels and, thereby, to ameliorate the accuracy of color Doppler in predicting the likelihood of benign versus malignant nature of nodules. Specific flow patterns, missed at color Doppler studies, have been indicated with power Doppler in some tumors of the liver and breast. In different settings, power Doppler also permitted to monitor serial blood flow changes after therapy and to display them as color intensity, allowing the observer to distinguish flow changes.
CONCLUSION: Although the actual role of power Doppler in changing patient management has not been assessed yet, this technique can depict flow which was previously undetectable, and thus permits an easier and more confident diagnosis in body regions where the ultrasound signal is weak because blood vessels are small.

Entities:  

Mesh:

Year:  1998        PMID: 9652513     DOI: 10.1016/s0720-048x(98)00054-0

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  17 in total

1.  A comparison of radionuclide thyroid angiography, (99m)Tc-MIBI scintigraphy and power Doppler ultrasonography in the differential diagnosis of solitary cold thyroid nodules.

Authors:  Koray Demirel; Ozlem Kapucu; Cem Yücel; Hakan Ozdemir; Göksun Ayvaz; Ferit Taneri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-01       Impact factor: 9.236

2.  The usefulness of power Doppler ultrasonography in differentiating primary and secondary Raynaud's phenomenon.

Authors:  Sang Il Lee; Sang Yong Lee; Wan Hee Yoo
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

3.  Prospective evaluation of scrotal ultrasound and intratesticular perfusion by color-coded duplex sonography (CCDS) in TESE patients with azoospermia.

Authors:  Bora Altinkilic; Adrian Pilatz; Thorsten Diemer; Julia Wolf; Martin Bergmann; Sarah Schönbrunn; Uwe Ligges; Hans-Christian Schuppe; Wolfgang Weidner
Journal:  World J Urol       Date:  2017-04-20       Impact factor: 4.226

4.  Ultrasound guided electrocoagulation in patients with chronic non-insertional Achilles tendinopathy: a pilot study.

Authors:  M Ilum Boesen; S Torp-Pedersen; M Juhl Koenig; R Christensen; H Langberg; P Hölmich; M Bachmann Nielsen; H Bliddal
Journal:  Br J Sports Med       Date:  2006-06-28       Impact factor: 13.800

5.  The vascularity of internal fistulae in Crohn's disease: an in vivo power Doppler ultrasonography assessment.

Authors:  G Maconi; G M Sampietro; A Russo; S Bollani; M Cristaldi; F Parente; F Dottorini; G Bianchi Porro
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

6.  Oncologic Angiogenesis Imaging in the clinic---how and why.

Authors:  Karen A Kurdziel; Liza Lindenberg; Peter L Choyke
Journal:  Imaging Med       Date:  2011-09

Review 7.  Ultrasonography for the diagnosis of carpal tunnel syndrome: an umbrella review.

Authors:  Ting-Yu Lin; Ke-Vin Chang; Wei-Ting Wu; Levent Özçakar
Journal:  J Neurol       Date:  2022-05-31       Impact factor: 6.682

8.  Power Doppler sonography in the assessment of synovial tissue of the knee joint in rheumatoid arthritis: a preliminary experience.

Authors:  M Carotti; F Salaffi; P Manganelli; D Salera; B Simonetti; W Grassi
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

Review 9.  Longitudinal microvascularity in Achilles tendinopathy (power Doppler ultrasound, magnetic resonance imaging time-intensity curves and the Victorian Institute of Sport Assessment-Achilles questionnaire): a pilot study.

Authors:  Paula J Richards; Iain W McCall; Christopher Day; John Belcher; Nicola Maffulli
Journal:  Skeletal Radiol       Date:  2009-08-27       Impact factor: 2.199

10.  Application of molecular ultrasound for imaging integrin expression.

Authors:  Fabian Kiessling; Jessica Gaetjens; Moritz Palmowski
Journal:  Theranostics       Date:  2011-02-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.